ALX Oncology (ALXO) PT Lowered to $85 but Jefferies Expects Shares to Bounce Back

May 18, 2021 9:02 AM EDT Send to a Friend
Jefferies analyst Michael Yee lowered the price target on ALX Oncology (NASDAQ: ALXO) to $85.00 (from $95.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login